| Single-cell RNA sequencing of childhood ependymoma reveals neoplastic cell subpopulations that impact molecular classification and etiology AE Gillen, KA Riemondy, V Amani, AM Griesinger, A Gilani, ... Cell reports 32 (6), 108023, 2020 | 56 | 2020 |
| Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma V Amani, EW Prince, I Alimova, I Balakrishnan, D Birks, AM Donson, ... BMC cancer 16 (1), 1-9, 2016 | 38 | 2016 |
| The inflammatory milieu of adamantinomatous craniopharyngioma and its implications for treatment R Whelan, E Prince, A Gilani, T Hankinson Journal of clinical medicine 9 (2), 519, 2020 | 35 | 2020 |
| Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors JA Lake, AM Donson, E Prince, KD Davies, A Nellan, AL Green, ... Pediatric blood & cancer 67 (1), e28028, 2020 | 34 | 2020 |
| Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma EW Prince, I Balakrishnan, M Shah, JMM Levy, AM Griesinger, I Alimova, ... Oncotarget 7 (33), 53881, 2016 | 31 | 2016 |
| Adamantinomatous craniopharyngioma: moving toward targeted therapies AC Hengartner, E Prince, T Vijmasi, TC Hankinson Neurosurgical Focus 48 (1), E7, 2020 | 30 | 2020 |
| Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma PC Flannery, JA DeSisto, V Amani, S Venkataraman, RT Lemma, ... Oncology reports 39 (2), 455-464, 2018 | 27 | 2018 |
| Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic images EW Prince, R Whelan, DM Mirsky, N Stence, S Staulcup, P Klimo, ... Scientific reports 10 (1), 1-13, 2020 | 25 | 2020 |
| Characterization of 2 novel ependymoma cell lines with chromosome 1q gain derived from posterior fossa tumors of childhood V Amani, AM Donson, SC Lummus, EW Prince, AM Griesinger, DA Witt, ... Journal of Neuropathology & Experimental Neurology 76 (7), 595-604, 2017 | 24 | 2017 |
| Targeting Polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor I Alimova, AM Pierce, P Harris, A Donson, DK Birks, E Prince, ... Oncotarget 8 (57), 97290, 2017 | 17 | 2017 |
| Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine DC Moreira, S Venkataraman, A Subramanian, J Desisto, I Balakrishnan, ... Journal of neuro-oncology 147 (3), 531-545, 2020 | 16 | 2020 |
| Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review R Whelan, A Hengartner, Z Folzenlogen, E Prince, TC Hankinson Child's Nervous System 36 (8), 1635-1642, 2020 | 15 | 2020 |
| Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma AM Pierce, DA Witt, AM Donson, A Gilani, B Sanford, M Sill, B Van Court, ... Neuro-oncology 21 (12), 1540-1551, 2019 | 15 | 2019 |
| Single-cell RNA sequencing of childhood ependymoma reveals neoplastic cell subpopulations that impact molecular classification and etiology. Cell Rep 32: 108023 AE Gillen, KA Riemondy, V Amani, AM Griesinger, A Gilani, ... | 7 | 2020 |
| Interrater reliability of a method to assess hypothalamic involvement in pediatric adamantinomatous craniopharyngioma R Whelan, E Prince, DM Mirsky, R Naftel, A Bhatia, B Pettorini, S Avula, ... Journal of Neurosurgery: Pediatrics 25 (1), 37-42, 2019 | 6 | 2019 |
| Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targets E Prince, R Whelan, A Donson, S Staulcup, A Hengartner, T Vijmasi, ... Acta neuropathologica communications 8 (1), 1-10, 2020 | 5 | 2020 |
| Uncertainty-Aware Deep Learning Classification of Adamantinomatous Craniopharyngioma from Preoperative MRI EW Prince, D Ghosh, C Görg, TC Hankinson Diagnostics 13 (6), 1132, 2023 | 4 | 2023 |
| Age-related changes in the completeness of the circle of Willis in children T Chopra, I Neuberger, E Prince, C White, J Maloney, N Stence, D Mirsky Child's Nervous System 38 (6), 1181-1184, 2022 | 3 | 2022 |
| MB-71THE ROLE OF WEE1 IN Myc-DRIVEN MEDULLOBLASTOMA D Moreira, S Venkataraman, I Balakrishnan, E Prince, N Foreman, ... Neuro-Oncology 18 (Suppl 3), iii113, 2016 | 3 | 2016 |
| Mb-22 checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in Myc-driven medulloblastoma E Prince, M Shah, S Venkataraman, I Balakrishnan, I Alimova, P Harris, ... Neuro-oncology 17 (suppl_3), iii24-iii24, 2015 | 3 | 2015 |
